Piper Jaffray & Co. initiates coverage on Covidien, Ltd. (NYSE: COV) with a Neutral. Price target $41.

Piper analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE